 |
IL-4 Pseudomonas Toxin Fusion Protein (IL-4(38-37)-PE38KDEL) |
|---|---|
| Trade Name | |
| Orphan Indication | Astrocytic glioma |
| USA Market Approval | USA |
| USA Designation Date | 2000-04-06 00:00:00 |
| Sponsor | Medicenna Therapeutics, Inc.;220-1075 West George Street, Vancouver, British Columbia; |
